About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Prostate Cancer Clinical Trials in Denver | 203 Studies

Clinical Trials Prostate CancerDenver

Prostate Cancer Clinical Trials in Denver

Find 203 clinical trials for prostate cancer near Denver, Colorado. Connect with research centers in your area.

All Prostate Cancer trials nationwide All trials in Denver

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 181-200 of 203 trials

CompletedEfficacy and Safety Study of Darolutamide (ODM-201) in Men With High-risk Non-metastatic Castration-resistant Prostate CancerThe purpose of this study is to assess the safety and efficacy of BAY1841788 (ODM-201) in patients with non-metastatic castration-resistant prostate cancer.NCT02200614·Homewood, Alabama and 403 others

Prostate Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

RecruitingStudy of HLD-0915 (JNJ-101556143) in Patients With Metastatic Prostate CancerAssessment of the safety and efficacy of HLD-0915 (JNJ-101556143) in patients with metastatic prostate cancer who have progressed on prior systemic therapies, with further…NCT06800313·Colorado Springs, Colorado and 17 others

RecruitingA Study of GSK5458514 Administered Alone or In Combination With Other Anti-Cancer Agents in Participants With Prostate CancerThe goal of the study is to evaluate how safe and how well the body handles GSK5458514 when administered in participants with prostate cancer.NCT06990880·Phoenix, Arizona and 19 others

TerminatedA Study of AC176 for the Treatment of Metastatic Castration Resistant Prostate CancerThis clinical trial is evaluating a drug called AC176 in participants with metastatic castration resistant prostate cancer (mCRPC) who have progressed on at least two prior…NCT05241613·Denver, Colorado and 4 others

Active not recruitingA Phase 1-2 Study of ST101 in Patients With Advanced Solid TumorsThis is an open-label, two-part, phase 1-2 dose-finding study designed to determine the safety, tolerability, PK, PD, and proof-of-concept efficacy of ST101 administered IV in…NCT04478279·San Francisco, California and 10 others

CompletedSpaceOAR System Pivotal StudyEvaluate the safety of the SpaceOAR System when the hydrogel is injected between the rectum and prostate in men undergoing radiation therapy (IG-IMRT)NCT01538628·Phoenix, Arizona and 19 others

CompletedSafety and Efficacy of CC-4047 in Subjects With Metastatic Hormone Refractory Prostate Cancer (HRPC)Phase II randomized open-label, two-arm study of safety and efficacy of CC-4047 in subjects with metastatic hormone refractory prostate cancer (HRPC)NCT00072722·Denver, Colorado and 1 other

CompletedProstate Cancer Study In Men Who Have Failed First-Line Androgen Deprivation TherapyDutasteride inhibits the conversion of testosterone to dihydrotestosterone (DHT) the male hormone that leads to benign prostate growth.NCT00470834·Homewood, Alabama and 61 others

TerminatedExtension Study Investigating the Long-Term Safety and Tolerability of Repeat Doses of FE200486 in Prostate Cancer PatientsParticipants responding well in Study FE200486 CS06 (NCT00117949) were given the opportunity to continue treatment with degarelix under a clinical study until FE200486 was…NCT00117312·Anaheim, California and 11 others

Active not recruitingA Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate CancerThe purpose of this study is to: a) establish the recommended phase 2 dose (RP2D) and to evaluate the antitumor activity and safety of niraparib combination therapies…NCT03431350·Tucson, Arizona and 49 others

Active not recruitingAn Efficacy and Safety Study of JNJ-56021927 (Apalutamide) in High-risk Prostate Cancer Subjects Receiving Primary Radiation Therapy: ATLASThe purpose of this study is to determine if apalutamide plus gonadotropin releasing hormone (GnRH) agonist in participants with high-risk, localized or locally advanced prostate…NCT02531516·Homewood, Alabama and 262 others

CompletedStudy Investigating the Pharmacokinetics, Pharmacodynamics and Safety of FE200486Population pharmacokinetic and pharmacodynamic data from Study FE200486 CS06 and FE200486 CS02 provided further knowledge of the optimal dose regimens for FE200486 (degarelix).NCT00117949·Anaheim, California and 11 others

CompletedRadiation Therapy With or Without Antiandrogen Therapy in Treating Patients With Stage I or Stage II Prostate CancerRATIONALE: Radiation therapy (RT) uses high-energy x-rays to damage tumor cells. Androgens can stimulate the growth of prostate cancer cells.NCT00002597·Birmingham, Alabama and 238 others

CompletedA Randomized, Double-blind, Phase 3 Efficacy Trial of PROSTVAC-V/F +/- GM-CSF in Men With Asymptomatic or Minimally Symptomatic Metastatic Castrate-Resistant Prostate CancerThe purpose of this study is to determine whether PROSTVAC alone or in combination with GM-CSF is effective in prolonging overall survival in men with few or no symptoms from…NCT01322490·Anchorage, Alaska and 219 others

Active not recruitingStudy of Cabozantinib Alone or in Combination With Atezolizumab to Subjects With Locally Advanced or Metastatic Solid TumorsThis is a multicenter Phase 1b, open-label study to assess safety, tolerability, preliminary efficacy, and pharmacokinetics (PK) of cabozantinib taken in combination with…NCT03170960·Gilbert, Arizona and 123 others

CompletedDolastatin 10 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Hormone TherapyRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00003626·Denver, Colorado and 2 others

TerminatedA Study of Galeterone Compared to Enzalutamide In Men Expressing Androgen Receptor Splice Variant-7 mRNA (AR-V7) Metastatic CRPCThe purpose of this study is to compare galeterone to enzalutamide in men expressing androgen receptor spice variant-7 mRNA (AR-V7) in metastatic (M1) castrate resistant prostate…NCT02438007·Scottsdale, Arizona and 116 others

CompletedIxabepilone in Treating Patients With Metastatic Prostate CancerDrugs used in chemotherapy, such as ixabepilone, work in different ways to stop tumor cells from dividing so they stop growing or die.NCT00087139·Aurora, Colorado and 161 others

CompletedTwo-Dose Level Evaluation of NX-1207 for the Treatment of Low Risk, Localized (T1c) Prostate CancerThis study is designed to evaluate the safety and efficacy of a single injection of NX-1207 for the treatment of biopsy-confirmed low risk localized (T1c) prostate cancer in…NCT01620515·Tucson, Arizona and 22 others

Active not recruitingTesting the Addition of the Drug Relugolix to the Usual Radiation Therapy for Advanced-Stage Prostate Cancer, The NRG Promethean StudyThis phase II trial compares the usual treatment of radiation therapy alone to using the study drug, relugolix, plus the usual radiation therapy in patients with…NCT05053152·Phoenix, Arizona and 244 others

PreviousPage 10 of 11Next

Other Conditions in Denver

Breast Cancer Lung Cancer Colorectal Cancer Melanoma Leukemia Lymphoma